Products Antibodies Polyclonal Antibodies Anti-TARS Polyclonal Antibody for WB, IHC-P, IF/ICC, ELISA - P26639
Anti-TARS Polyclonal Antibody for WB, IHC-P, IF/ICC, ELISA - P26639

Polyclonal Antibodies

Anti-TARS Polyclonal Antibody for WB, IHC-P, IF/ICC, ELISA - P26639

Item Number : CM0026689

Price varies based on specs and customizations


Application
WB, IHC-P, IF/ICC, ELISA
Cross Reactivity
Human, Mouse, Rat
Protein Weight
83kDa
ISO & CE icon

Shipping:

Contact us to get shipping details Enjoy On-time Dispatch Guarantee.

View Specs

Why Choose Us

Easy ordering process, quality products, and dedicated support for your business success.

Easy Process Quality Assured Dedicated Support

Core Product Specifications and Parameters

Parameter Value
Product Name TARS Rabbit pAb
Remarks/Alias TARS; TTD7; ThrRS
Species Human
Gene ID (Human) 6897
Immunogen Recombinant fusion protein containing a sequence corresponding to amino acids 1-230 of human TARS (NP_689508.3)
Source Rabbit
Category Polyclonal Antibodies
Application WB, IHC-P, IF/ICC, ELISA
Cross Reactivity Human, Mouse, Rat
SWISS P26639
Protein Weight 83kDa
Shipping Ice bag

Biological Background: Threonine--tRNA Ligase 1 Function and Localization

  • Threonine--tRNA ligase 1, cytoplasmic (TARS, also known as TARS1, ThrRS), is a member of the aminoacyl-tRNA synthetase family that specifically charges tRNA(Thr) with threonine.
  • Catalyzes the attachment of threonine to tRNA(Thr) via a two-step mechanism: threonine activation by ATP to form Thr-AMP, followed by transfer to the acceptor end of tRNA(Thr) (PubMed:25824639, PubMed:31374204). Related references: PMID:25824639, PMID:31374204
  • Possesses an editing domain that hydrolytically removes mischarged amino acids from tRNA(Thr) at the post-transfer stage, ensuring high fidelity of protein synthesis (By similarity).
  • Localizes predominantly to the cytoplasm, where it functions in translational elongation.
  • Subject to multiple post-translational modifications including acetylation, phosphorylation, and ubiquitin-like conjugation; also exhibits alternative splicing.
  • Contains disease-associated variants (keyword: Disease variant), implicating TARS in human pathology.
  • Structural studies (3D-structure keyword) have provided insights into its catalytic and editing domains.

Experimental Guidance and Technical Tips

  • The antibody is raised against a recombinant immunogen corresponding to the N-terminal region (amino acids 1–230) of human TARS. Confirm reactivity with your target of interest in relevant species (human, mouse, rat).
  • For Western blot (WB), use appropriate protein loading controls and validate band specificity using knockdown or knockout cell lysates if available.
  • In immunohistochemistry (IHC-P), optimize antigen retrieval and antibody dilution; include positive and negative tissue controls.
  • For immunofluorescence (IF/ICC), consider fixation and permeabilization conditions suitable for cytoplasmic targets.
  • The polyclonal nature may recognize multiple isoforms or modified forms; validate in your experimental system.

CamelBio: Your One-Stop Sourcing Bridge

CamelBio serves as a comprehensive one-stop partner for IVD raw-material sourcing, technical support, and consultative services from concept to clinic. This anti-TARS polyclonal antibody is ideal for research in protein translation, aminoacyl-tRNA synthetase biology, and related disease areas. Beyond individual antibodies, CamelBio offers validated antibody pairs, optimized monoclonal/polyclonal antibodies, bulk ancillary reagents, and custom sourcing for rare targets to support your diagnostic and research pipelines.

View more faqs for this product

Product Datasheet

Anti-TARS Polyclonal Antibody for WB, IHC-P, IF/ICC, ELISA - P26639


REQUEST A QUOTE

Our professional team will reply to you within one business day. Please feel free to contact us!